Marko Anderluh

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 25

Top Topics

Silver Nanoparticles

Immune Response

Staphylococcus Aureus

Top Venues

Antibiotics (Basel, Switzerland)

Medicinal research reviews

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Edvin Purić, Ulf J Nilsson, Marko Anderluh
Galectin-8 inhibition and functions in immune response and tumor biology. Medicinal research reviews 44 (5) (2024)
Edvin Purić, Ulf J Nilsson, Marko Anderluh
Galectin-8 inhibition and functions in immune response and tumor biology. Medicinal research reviews (2024)
Janja Sluga, Tihomir Tomašič, Marko Anderluh, Martina Hrast Rambaher, Gregor Bajc, Alen Sevšek, Nathaniel I Martin, Roland J Pieters, Marjana Novič, Katja Venko
Targeting N -Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Edvin Purić, Ulf J Nilsson, Marko Anderluh
Galectin-8 inhibition and functions in immune response and tumor biology. Medicinal research reviews 44 (5) (2024)
Janja Sluga, Tihomir Tomašič, Marko Anderluh, Martina Hrast Rambaher, Gregor Bajc, Alen Sevšek, Nathaniel I Martin, Roland J Pieters, Marjana Novič, Katja Venko
Targeting N -Acetylglucosaminidase in Staphylococcus aureus with Iminosugar Inhibitors. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Sjors van Klaveren, Mujtaba Hassan, Maria Håkansson, Richard E Johnsson, Jessica Larsson, Žiga Jakopin, Marko Anderluh, Hakon Leffler, Tihomir Tomašič, Ulf J Nilsson
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket. ACS medicinal chemistry letters 15 (8) (2024)
Sjors van Klaveren, Mujtaba Hassan, Maria Håkansson, Richard E Johnsson, Jessica Larsson, Žiga Jakopin, Marko Anderluh, Hakon Leffler, Tihomir Tomašič, Ulf J Nilsson
Galectin-8N-Selective 4-Halophenylphthalazinone-Galactals Double π-Stack in a Unique Pocket. ACS medicinal chemistry letters 15 (8) (2024)
Maja Kokot, Doroteja Novak, Irena Zdovc, Marko Anderluh, Martina Hrast Rambaher, Nikola Minovski
Exploring Alternative Pathways to Target Bacterial Type II Topoisomerases Using NBTI Antibacterials: Beyond Halogen-Bonding Interactions. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Sjors van Klaveren, Jaka Dernovšek, Žiga Jakopin, Marko Anderluh, Hakon Leffler, Ulf J Nilsson, Tihomir Tomašič
Design and synthesis of novel 3-triazolyl-1-thiogalactosides as galectin-1, -3 and -8 inhibitors. RSC advances 12 (29) (2022)
Mihajlo Gajic, Damijan Knez, Gobec Izidor Sosič, Janez Mravljak, Anže Meden, Urban Košak, Luisa Leitzbach, Sven George, Bettina Hofmann, Aleksandra Zivkovic, Dieter Steinhilber, Holger Stark, Stanislav Gobec, Andrija Šmelcerović, Marko Anderluh
Repurposing of 8-Hydroxyquinoline-Based Butyrylcholinesterase and Cathepsin B Ligands as Potent Nonpeptidic Deoxyribonuclease I Inhibitors. ChemMedChem 17 (5) (2022)
Elena M Loi, Tihomir Tomašič, Cyril Balsollier, Kevin van Eekelen, Matjaž Weiss, Martina Gobec, Matthew G Alteen, David J Vocadlo, Roland J Pieters, Marko Anderluh
Discovery of a New Drug-like Series of OGT Inhibitors by Virtual Screening. Molecules (Basel, Switzerland) 27 (6) (2022)
Maja Kokot, Marko Anderluh, Martina Hrast, Nikola Minovski
The Structural Features of Novel Bacterial Topoisomerase Inhibitors That Define Their Activity on Topoisomerase IV. Journal of medicinal chemistry 65 (9) (2022)
Anja Kolarič, Maja Kokot, Martina Hrast Rambaher, Matjaž Weiss, Irena Zdovc, Jurij Trontelj, Simon Žakelj, Marko Anderluh, Nikola Minovski
A Fine-Tuned Lipophilicity/Hydrophilicity Ratio Governs Antibacterial Potency and Selectivity of Bifurcated Halogen Bond-Forming NBTIs. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Benedetta Girardi, Martina Manna, Sjors Van Klaveren, Tihomir Tomašič, Žiga Jakopin, Hakon Leffler, Ulf J Nilsson, Daniel Ricklin, Janez Mravljak, Oliver Schwardt, Marko Anderluh
Selective Monovalent Galectin-8 Ligands Based on 3-Lactoylgalactoside. ChemMedChem (2021)
Maja Kokot, Matjaž Weiss, Irena Zdovc, Martina Hrast, Marko Anderluh, Nikola Minovski
Structurally Optimized Potent Dual-Targeting NBTI Antibacterials with an Enhanced Bifurcated Halogen-Bonding Propensity. ACS medicinal chemistry letters 12 (9) (2021)
Anja Kolarič, Thomas R M Germe, Martina Hrast Rambaher, Clare E M Stevenson, David M Lawson, Nicolas P Burton, Judit Vörös, Anthony Maxwell, Nikola Minovski, Marko Anderluh
Potent DNA gyrase inhibitors bind asymmetrically to their target using symmetrical bifurcated halogen bonds. Nature communications 12 (1) (2021)
Matjaž Weiss, Marko Anderluh, Martina Gobec
Inhibition of O-GlcNAc Transferase Alters the Differentiation and Maturation Process of Human Monocyte Derived Dendritic Cells. Cells 10 (12) (2021)
Gordana Kocic, Mihajlo Gajic, Katarina Tomovic, Jovan Hadzi-Djokic, Marko Anderluh, Andrija Smelcerovic
Purine adducts as a presumable missing link for aristolochic acid nephropathy-related cellular energy crisis, potential anti-fibrotic prevention and treatment. British journal of pharmacology 178 (22) (2021)
Cyril Balsollier, Roland J Pieters, Marko Anderluh
Overview of the Assays to Probe O-Linked β-N-Acetylglucosamine Transferase Binding and Activity. Molecules (Basel, Switzerland) 26 (4) (2021)
Mujtaba Hassan, Floriane Baussière, Samo Guzelj, Anders P Sundin, Maria Håkansson, Rebeka Kovačič, Hakon Leffler, Tihomir Tomašič, Marko Anderluh, Žiga Jakopin, Ulf J Nilsson
Structure-Guided Design of d-Galactal Derivatives with High Affinity and Selectivity for the Galectin-8 N-Terminal Domain. ACS medicinal chemistry letters 12 (11) (2021)
Doroteja Novak, Tihomir Tomašič, Marko Krošelj, Uroš Javornik, Janez Plavec, Marko Anderluh, Petra Kolenc Peitl
Radiolabelled CCK2 R Antagonists Containing PEG Linkers: Design, Synthesis and Evaluation. ChemMedChem 16 (1) (2020)
Elena Maria Loi, Matjaž Weiss, Stane Pajk, Martina Gobec, Tihomir Tomašič, Roland J Pieters, Marko Anderluh
Intracellular Hydrolysis of Small-Molecule O-Linked N-Acetylglucosamine Transferase Inhibitors Differs among Cells and Is Not Required for Its Inhibition. Molecules (Basel, Switzerland) 25 (15) (2020)
Anja Kolarič, Marko Anderluh, Nikola Minovski
Two Decades of Successful SAR-Grounded Stories of the Novel Bacterial Topoisomerase Inhibitors (NBTIs). Journal of medicinal chemistry 63 (11) (2020)
Katarina Tomovic, Jelena Lazarevic, Gordana Kocic, Marina Deljanin-Ilic, Marko Anderluh, Andrija Smelcerovic
Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. Medicinal research reviews 39 (1) (2018)
Hao Zhang, Tihomir Tomašič, Jie Shi, Matjaž Weiss, Rob Ruijtenbeek, Marko Anderluh, Roland J Pieters
Inhibition of O-GlcNAc transferase (OGT) by peptidic hybrids. MedChemComm 9 (5) (2018)